scholarly journals Computational Model of Parkinson's Disease Pathology in Olfactory Bulb Predicts Localization of Neural Activity and Disruption to Oscillatory Behavior

2020 ◽  
Vol 118 (3) ◽  
pp. 287a-288a
Author(s):  
Kendall Berry ◽  
Daniel L. Cox
2020 ◽  
Author(s):  
J. Kendall Berry ◽  
Daniel L. Cox

AbstractThe olfactory bulb (OB) is one of the first regions of the brain affected by Parkinson’s disease (PD) as measured by both dysfunction and presence of α-synuclein aggregation. Better understanding of how PD affects OB function could lead to earlier diagnosis and potential treatment. By simulating damage to the OB in a computational model, it may be possible to identify regions of interest or markers of early disease. We modified a simple rate-based computational model of the olfactory bulb and simulated damage to various components of the network. This was done for several configurations of the network, at different sizes and with 1D and 2D connectivity structures. We found that, in almost every case, activity of 2D networks were more robust to damage than 1D networks, leading us to conclude that a connection scheme of at least 2D is vital to computational modeling of the OB. We also found that certain types of damage (namely, seeded damage to the granule cell layer and to the synapses between mitral and granule cells) resulted in a peak of the oscillatory power of the network as a function of damage. This result is testable experimentally and bears further investigation utilizing more sophisticated computational models. If proven accurate, this rise in oscillatory power in the OB has the potential to be an early marker of PD.Author summaryOne of the first symptoms of Parkinson’s disease is the degradation of the sense of smell. The olfactory bulb is the first region of the brain to process odor information and is affected by Parkinson’s disease at early stages. We simulated neural activity in a computational model of the olfactory bulb in the presence of damage and compared it to simulations of undamaged activity. We found that 2D model networks were more robust to damage than their 1D counterparts. We also found that 2D networks displayed increased oscillatory activity when damage was applied to certain parts of the network. This last result, if proven correct, would potentially be a marker of early-stage Parkinson’s disease, and if so, could aid in early diagnosis and treatment of the disease.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jui-Chih Chang ◽  
Yi-Chun Chao ◽  
Huei-Shin Chang ◽  
Yu-Ling Wu ◽  
Hui-Ju Chang ◽  
...  

AbstractThe feasibility of delivering mitochondria intranasally so as to bypass the blood–brain barrier in treating Parkinson's disease (PD), was evaluated in unilaterally 6-OHDA-lesioned rats. Intranasal infusion of allogeneic mitochondria conjugated with Pep-1 (P-Mito) or unconjugated (Mito) was performed once a week on the ipsilateral sides of lesioned brains for three months. A significant improvement of rotational and locomotor behaviors in PD rats was observed in both mitochondrial groups, compared to sham or Pep-1-only groups. Dopaminergic (DA) neuron survival and recovery > 60% occurred in lesions of the substantia nigra (SN) and striatum in Mito and P-Mito rats. The treatment effect was stronger in the P-Mito group than the Mito group, but the difference was insignificant. This recovery was associated with restoration of mitochondrial function and attenuation of oxidative damage in lesioned SN. Notably, P-Mito suppressed plasma levels of inflammatory cytokines. Mitochondria penetrated the accessory olfactory bulb and doublecortin-positive neurons of the rostral migratory stream (RMS) on the ipsilateral sides of lesions and were expressed in striatal, but not SN DA neurons, of both cerebral hemispheres, evidently via commissural fibers. This study shows promise for intranasal delivery of mitochondria, confirming mitochondrial internalization and migration via RMS neurons in the olfactory bulb for PD therapy.


2015 ◽  
Vol 230 (7) ◽  
pp. 1614-1629 ◽  
Author(s):  
Hany E.S. Marei ◽  
Samah Lashen ◽  
Amany Farag ◽  
Asmaa Althani ◽  
Nahla Afifi ◽  
...  

Antioxidants ◽  
2020 ◽  
Vol 9 (10) ◽  
pp. 928
Author(s):  
Jung Hwa Seo ◽  
Seong-Woong Kang ◽  
Kyungri Kim ◽  
Soohyun Wi ◽  
Jang Woo Lee ◽  
...  

Although environmental enrichment (EE) is known to reduce oxidative stress in Parkinson’s disease (PD), the metabolic alternations for detoxifying endogenous and xenobiotic compounds according to various brain regions are not fully elucidated yet. This study aimed to further understand the role of EE on detoxifying enzymes, especially those participating in phase I of metabolism, by investigating the levels of enzymes in various brain regions such as the olfactory bulb, brain stem, frontal cortex, and striatum. Eight-month-old transgenic PD mice with the overexpression of human A53T α-synuclein and wild-type mice were randomly allocated to either standard cage condition or EE for 2 months. At 10 months of age, the expression of detoxifying enzymes was evaluated and compared with wild-type of the same age raised in standard cages. EE improved neurobehavioral outcomes such as olfactory and motor function in PD mice. EE-treated mice showed that oxidative stress was attenuated in the olfactory bulb, brain stem, and frontal cortex. EE also reduced apoptosis and induced cell proliferation in the subventricular zone of PD mice. The overexpression of detoxifying enzymes was observed in the olfactory bulb and brain stem of PD mice, which was ameliorated by EE. These findings were not apparent in the other experimental regions. These results suggest the stage of PD pathogenesis may differ according to brain region, and that EE has a protective effect on the PD pathogenesis by decreasing oxidative stress.


Sign in / Sign up

Export Citation Format

Share Document